Filing Details
- Accession Number:
- 0001104659-22-052419
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-28 17:23:55
- Reporting Period:
- 2022-04-26
- Accepted Time:
- 2022-04-28 17:23:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1442836 | Mersana Therapeutics Inc. | MRSN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645755 | Alejandra Carvajal | C/O Mersana Therapeutics, Inc. 840 Memorial Drive Cambridge MA 02139 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-04-26 | 13,250 | $0.00 | 13,250 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-04-26 | 3,948 | $3.69 | 9,302 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted stock unit | Disposition | 2022-04-26 | 13,250 | $0.00 | 13,250 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,250 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock received upon the vesting of a portion of the restricted stock units ("RSUs") awarded to the Reporting Person on April 26, 2021.
- Represents the sale of shares of common stock to satisfy the Reporting Person's tax withholding obligations in connection with the service-based vesting and settlement of the RSUs.
- Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- The RSUs vested as to 50% of the shares on April 26, 2022 and will vest as to 50% of the shares on April 26, 2023, subject to the Reporting Person's continued service to the Issuer on such date.